Keyword

TRC105

Description: TRC105 is an investigational monoclonal antibody targeting endoglin, studied as a cancer therapy in clinical trials and combination treatments.
OpenAlex ID: keywords/trc105
2012 · Lee S. Rosen, Herbert I. Hurwitz, et al. · Clinical Cancer Research · 175
2018 · Madelon Paauwe, Mark J.A. Schoonderwoerd, et al. · Clinical Cancer Research · 173
2010 · Ben K. Seon, Akinao Haba, et al. · Current Drug Delivery · 136
2020 · Mark J.A. Schoonderwoerd, Marie-Jose T.H. Goumans, et al. · Biomolecules · 127
2013 · Jintang Guo, Hao Hong, et al. · Biomaterials · 105
2015 · Stephen A. Graves, Reinier Hernandez, et al. · Bioconjugate Chemistry · 99
2014 · Lee S. Rosen, Michael S. Gordon, et al. · Current Oncology Reports · 92
2011 · Hao Hong, Gregory W. Severin, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 82
2011 · Hao Hong, Yunan Yang, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 79
2018 · Hongyu Tian, Jennifer J. Huang, et al. · The FASEB Journal · 75
2014 · Fatima H. Karzai, Andrea B. Apolo, et al. · British Journal of Urology · 61
2016 · Andrea B. Apolo, Fatima H. Karzai, et al. · Clinical Genitourinary Cancer · 57
2014 · Yingmiao Liu, Hongyu Tian, et al. · Investigational New Drugs · 50
Works count: 173
Citation count: 3,433
Year
Topic
Type